Chitnis T, Arnold DL, Banwell B, et al. PARADIGMS: a randomised double-blind study of fingolimod versus interferon β-1a in paediatric multiple sclerosis. ECTRIMS 2017, #276.
Wienke-groep van Prinses Máxima Centrum focust op CAR T-celtherapie bij solide tumoren
sep 2025 | Immuuntherapie